Provided by Tiger Fintech (Singapore) Pte. Ltd.

Castle Biosciences, Inc.

18.83
+0.29001.56%
Volume:110.37K
Turnover:2.04M
Market Cap:543.67M
PE:-102.07
High:18.86
Open:18.51
Low:17.89
Close:18.54
Loading ...

Castle Biosciences (CSTL) Gets a Buy from Scotiabank

TIPRANKS
·
03 Mar

What Is Castle Biosciences, Inc.'s (NASDAQ:CSTL) Share Price Doing?

Simply Wall St.
·
01 Mar

Castle Biosciences Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
01 Mar

Q4 2024 Castle Biosciences Inc Earnings Call

Thomson Reuters StreetEvents
·
01 Mar

Castle Biosciences Is Maintained at Outperform by Baird

Dow Jones
·
28 Feb

Castle Biosciences price target raised to $37 from $36 at Baird

TIPRANKS
·
28 Feb

Castle Biosciences Inc (CSTL) Q4 2024 Earnings Call Highlights: Record Revenue Growth and ...

GuruFocus.com
·
28 Feb

Castle Biosciences, Inc. (CSTL) Surpasses Q4 Earnings and Revenue Estimates

Zacks
·
28 Feb

Castle Biosciences sees FY25 revenue $280M-$295M, consensus $269.06M

TIPRANKS
·
28 Feb

Castle Biosciences Q4 2024 GAAP EPS $0.32 Up From $(0.10) YoY, Sales $86.311M Beat $81.911M Estimate

Benzinga
·
28 Feb

BRIEF-Castle Biosciences Q4 Revenue USD 86.311 Million Vs. IBES Estimate USD 81.9 Million

Reuters
·
28 Feb

Castle Biosciences Inc - Expects 2025 Revenue Between $280-295 Million

THOMSON REUTERS
·
28 Feb

Castle Biosciences Inc FY2025 REV View $274.1 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
28 Feb

Castle Biosciences Reports Fourth Quarter and Full-Year 2024 Results

Business Wire
·
28 Feb

Castle Biosciences to Participate in Upcoming Investor Conferences

Business Wire
·
26 Feb

CSTL Gears Up to Report Q4 Earnings: Here's What You Should Know

Zacks
·
25 Feb

Surging Earnings Estimates Signal Upside for Castle Biosciences (CSTL) Stock

Zacks
·
13 Feb

Are Medical Stocks Lagging Adaptive Biotechnologies (ADPT) This Year?

Zacks
·
12 Feb

IMVT Q3 Loss Wider Than Expected, Stock Down, Pipeline in Focus

Zacks
·
07 Feb

DNLI Reports Upbeat Longer-Term Data From Hunter Syndrome Study

Zacks
·
07 Feb